Page 109 - AN-4-1
P. 109
Advanced Neurology TDP-43 regulates IFN1 production
Supervision: Wenjuan Zhang, Daihe Yang, Guohua Song doi: 10.1007/s00401-008-0402-2
Validation: Wenjuan Zhang, Cao Huang 8. Bose JK, Huang CC, James Shen CK. Regulation of
Visualization: Zhen Yi, Yifan Hao, Feng Zhou autophagy by neuropathological protein TDP-43. J Biol
Writing – original draft: Cao Huang, Bo Huang Chem. 2011;286(52):44441-44448.
Writing – review & editing: Zhen Yi, Yifan Hao, Cao Huang, doi: 10.1074/jbc.M111.237115
Yun Zhou, Bo Huang
9. Foster AD, Downing P, Figredo E, et al. ALS-associated TBK1
Ethics approval and consent to participate variant p.G175S is defective in phosphorylation of p62 and
impacts TBK1-mediated signalling and TDP-43 autophagic
Not applicable. degradation. Mol Cell Neurosci. 2020;108:103539.
Consent for publication doi: 10.1016/j.mcn.2020.103539
Not applicable. 10. Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2
cause dominant X-linked juvenile and adult-onset ALS and
Availability of data ALS/dementia. Nature. 2011;477(7363):211-215.
All data are available from the co-authors on reasonable doi: 10.1038/nature10353
request. 11. Murray ME, DeJesus-Hernandez M, Rutherford NJ, et al.
Clinical and neuropathologic heterogeneity of c9FTD/
References ALS associated with hexanucleotide repeat expansion in
C9ORF72. Acta Neuropathol. 2011;122(6):673-690.
1. Weskamp K, Tank EM, Miguez R, et al. Shortened TDP
43
isoforms upregulated by neuronal hyperactivity drive TDP doi: 10.1007/s00401-011-0907-y
43
pathology in ALS. J Clin Invest. 2020;130(3):1139-1155. 12. Smith BN, Vance C, Scotter EL, et al. Novel mutations
doi: 10.1172/JCI130988 support a role for profilin 1 in the pathogenesis of ALS.
Neurobiol Aging. 2015;36(3):1602.e17-e27.
2. Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK.
Molecular mechanisms of TDP-43 misfolding and pathology doi: 10.1016/j.neurobiolaging.2014.10.032
in amyotrophic lateral sclerosis. Front Mol Neurosci. 13. Oakes JA, Davies MC, Collins MO. TBK1: A new player in
2019;12:25. ALS linking autophagy and neuroinflammation. Mol Brain.
doi: 10.3389/fnmol.2019.00025 2017;10(1):5.
3. Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Long doi: 10.1186/s13041-017-0287-x
pre-mRNA depletion and RNA missplicing contribute to 14. Marchlik E, Thakker P, Carlson T, et al. Mice lacking Tbk1
neuronal vulnerability from loss of TDP-43. Nat Neurosci. activity exhibit immune cell infiltrates in multiple tissues
2011;14(4):459-468. and increased susceptibility to LPS-induced lethality.
doi: 10.1038/nn.2779 J Leukoc Biol. 2010;88(6):1171-1180.
4. Liu G, Coyne AN, Pei F, et al. Endocytosis regulates TDP-43 doi: 10.1189/jlb.0210071
toxicity and turnover. Nat Commun. 2017;8(1):2092. 15. Chen T, Zhang W, Huang B, Chen X, Huang C. UBQLN2
doi: 10.1038/s41467-017-02017-x promotes the production of type I interferon via the TBK1-
IRF3 pathway. Cells. 2020;9(5):1205.
5. Xia Q, Wang H, Hao Z, et al. TDP-43 loss of function
increases TFEB activity and blocks autophagosome- doi: 10.3390/cells9051205
lysosome fusion. EMBO J. 2016;35(2):121-142. 16. Liu YJ. IPC: Professional type 1 interferon-producing cells
doi: 10.15252/embj.201591998 and plasmacytoid dendritic cell precursors. Annu Rev
Immunol. 2005;23:275-306.
6. Wang W, Wang L, Lu J, et al. The inhibition of TDP-43
mitochondrial localization blocks its neuronal toxicity. Nat doi: 10.1146/annurev.immunol.23.021704.115633
Med. 2016;22(8):869-878. 17. Honda K, Yanai H, Negishi H, et al. IRF-7 is the master
regulator of type-I interferon-dependent immune responses.
doi: 10.1038/nm.4130
Nature. 2005;434(7034):772-777.
7. Hiji M, Takahashi T, Fukuba H, Yamashita H, Kohriyama T,
Matsumoto M. White matter lesions in the brain with doi: 10.1038/nature03464
frontotemporal lobar degeneration with motor neuron disease: 18. Wang J, Yang B, Hu Y, et al. Negative regulation of Nmi on
TDP-43-immunopositive inclusions co-localize with p62, but virus-triggered type I IFN production by targeting IRF7.
not ubiquitin. Acta Neuropathol. 2008;116(2):183-191. J Immunol. 2013;191(6):3393-3399.
Volume 4 Issue 1 (2025) 103 doi: 10.36922/an.6272

